![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Author: Blakey D.
Publisher: Informa Healthcare
ISSN: 1354-3776
Source: Expert Opinion on Therapeutic Patents, Vol.7, Iss.9, 1997-09, pp. : 965-977
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Cytochrome P450 Gene-directed Enzyme Prodrug Therapy (GDEPT) for Cancer
Current Pharmaceutical Design, Vol. 8, Iss. 15, 2002-07 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Gene-directed enzyme prodrug therapy:
By Niculescu-Duvaz I. Springer C.J.
Expert Opinion on Investigational Drugs, Vol. 6, Iss. 6, 1997-06 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Prodrug strategies in cancer therapy
By Denny W.A.
European Journal of Medicinal Chemistry, Vol. 36, Iss. 7, 2001-08 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Advances in Imaging Gene-Directed Enzyme Prodrug Therapy
Current Pharmaceutical Biotechnology, Vol. 12, Iss. 4, 2011-04 ,pp. :